← Leaderboards
Richard C Harvey
University Of New Mexico Health Scis Ctr
$772,500
Attributed
$772,500
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $154.5K · FY2016–20$200K$150K$100K$50K$0
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$772,500 · 1
By mechanism
R50$772,500 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of New Mexico Health Scis Ctr
Same institution · by research overlap
- C Jeffrey Brinker$2,079,432
- Jeremy P Hogeveen$2,866,781
- Christina Marie Termini$1,086,117
- Muskan Floren$83,602
- Diane Lidke$11,381,606
Others in their field
Top investigators on “Tyrosine Kinase Inhibitor”
- Pasi A Janne · Stanford University$23,368,604
- Nicholas K Tonks · Cold Spring Harbor Laboratory$17,099,601
- Thomas J. Kipps · University Of California San Diego$15,116,707
- Garrett M Brodeur · Children'S Hospital Of Philadelphia$14,311,929
- Richard A. Van Etten · Immune Disease Institute, Inc.$14,167,441
- Mark A. Lemmon · Yale University$13,757,202
Research focus
Tyrosine Kinase InhibitorSubgroupTargeted AgentTargeted TreatmentTranscriptome SequencingTranscriptomicsAbl1 GeneAcute LeukemiaAdultCessation Of LifeCharacteristicsChildhoodClinical TrialsCohortCytogeneticsDiagnosisDiagnosticDisease ManagementDrug TargetingEvaluationEventGene ExpressionGene Expression ProfileGene Expression Profiling
Grant awards (5)
Integration of gene expression patterns, fusions, mutations, cytogenetics and other clinical variables for subtyping leukemias and targeting therapies$154,500
R50 · FY2020 · CA · contact PI
Integration of gene expression patterns, fusions, mutations, cytogenetics and other clinical variables for subtyping leukemias and targeting therapies$154,500
R50 · FY2019 · CA · contact PI
Integration of gene expression patterns, fusions, mutations, cytogenetics and other clinical variables for subtyping leukemias and targeting therapies$154,500
R50 · FY2018 · CA · contact PI
Integration of gene expression patterns, fusions, mutations, cytogenetics and other clinical variables for subtyping leukemias and targeting therapies$154,500
R50 · FY2017 · CA · contact PI
Integration of gene expression patterns, fusions, mutations, cytogenetics and other clinical variables for subtyping leukemias and targeting therapies$154,500
R50 · FY2016 · CA · contact PI